Skip to main content
. 2023 Jun 6;15(12):3072. doi: 10.3390/cancers15123072

Table 2.

Comparison of demographic characteristics and outcomes between childhood acute myeloid leukemia patients with and without hyperleukocytosis.

Variables Total
(N = 207)
Hyperleukocytosis
(N = 42)
No Hyperleukocytosis
(N = 165)
p Value
Demographic and clinical characteristics, n (%)
Age (months), median (IQR) 65.0 (25.5–133.5) 137.0 (34.0–150.5) 58.0 (25.0–116.0) 0.021
Sex 0.268
  Male 125 (60.4) 29 (69.0) 96 (58.2)
  Female 82 (39.6) 13 (31.0) 69 (41.8)
Fever 157 (75.8) 39 (92.9) 118 (71.5) 0.007
Hepatomegaly 165 (79.7) 37 (88.1) 128 (77.6) 0.194
Splenomegaly 119 (57.5) 31 (73.8) 88 (53.3) 0.026
Lymphadenopathy 142 (68.6) 35 (83.3) 107 (64.8) 0.034
Laboratory parameters, mean (SD)
Hemoglobin (g/dL) 7.3 (2.2) 7.1 (1.6) 7.3 (2.3) 0.585
Platelet count (×109/L) 64.1 (93.1) 50.0 (35.3) 67.7 (102.5) 0.272
Blast cells (%) 43.4 (34.7) 80.5 (24.7) 33.9 (30.3) <0.001
Calcium (mmol/L) 9.3 (0.7) 9.0 (0.9) 9.3 (0.7) 0.021
Phosphorus (mmol/L) 4.6 (1.2) 4.1 (1.4) 4.8 (1.0) <0.001
Uric acid (mmol/L) 5.0 (2.1) 6.0 (2.6) 4.8 (1.9) <0.001
Lactate dehydrogenase (U/L) 2035.6 (2210.0) 2619.7 (2425.5) 1888.6 (2135.3) 0.058
Treatment-related complications, n (%)
Tumor lysis syndrome 11 (5.3) 4 (9.5) 7 (4.2) 0.276
Seizure 8 (3.9) 1 (2.4) 7 (4.2) 1
Intracranial hemorrhage 2 (1.0) 2 (4.8) 0 (0) 0.037
Acute kidney injury 14 (6.8) 2 (4.8) 12 (7.3) 1
Septic shock 59 (28.5) 11 (26.2) 48 (29.1) 1
DIC 49 (23.7) 13 (31.0) 36 (21.8) 0.219
ETT intubation 41 (19.8) 8 (19.0) 33 (20.0) 1
ICU admission 46 (22.2) 11 (26.2) 35 (21.2) 0.504
Treatment outcomes, n (%)
Induction of remission 109 (67.3) 19 (59.3) 90 (69.2) 0.289
Relapse 63 (30.4) 12 (28.6) 51 (30.9) 0.915
Mortality 160 (77.3) 34 (81.0) 126 (76.4) 0.669

Values are expressed as n (%), mean (SD), or median (IQR). DIC, disseminated intravascular coagulopathy; ETT, endotracheal tube; ICU, intensive care unit.